2018 Straumann-botiss YoungPro Award goes to Piero Papi

Basel/Berlin, 12 November 2018 : At the botiss bone & tissue World Congress in Berlin, the 2018 Straumann-botiss YoungPro Award in Regenerative Dentistry was presented to Dr Piero Papi from Sapienza University in Rome, for his work on implant placement and bone augmentation in the esthetic area of the mouth. The award is sponsored by Straumann and botiss and is worth €10 000.


The winning entry

Entitled ‘Immediate implant placement and peri-implant augmentation with a porcine-derived acellular dermal matrix (Mucoderm®) and synthetic bone (Maxresorb®) in the esthetic area’, Dr Papi’s winning submission covers 15 single-tooth replacements in the front of the mouth, performed in 15 patients up to 8 weeks after tooth extraction. A guided-bone regeneration procedure, using a synthetic bone-graft together with a 3-dimensional matrix was performed in each case to build up bone around the implant. Dr Papi’s work shows that the contour and attachment of the gingiva around the implant was successfully augmented and remained stable after 12 months. His entry will be published on STARGET, https://www.straumann.com/en/discover/news.html.


The Award

The Straumann-botiss YoungPro Award is a bi-annual prize, which was created in 2015 with the aim of fostering and encouraging the development of young dental professionals in the field of regenerative dentistry and dental biomaterials research. Dental practitioners, students, researchers, etc. under the age of 35 compete for the prize by submitting original work that contributes to the advancement of treatment/care or research in regenerative dentistry. The winner receives a cash prize of €10 000 and the top three entrants win a trip to the bone & tissue days World Congress in Berlin. The previous winners are Dr Andreas Pabst (Germany) and Dr Vitor Sapata (Brazil).


The 2018 winner

Piero Papi, DDS is a Research Fellow in the Oral Surgery Unit of the Department of Oral and Maxillo-Facial Sciences at Sapienza University in Rome, Italy. He also serves as a Teaching Assistant of Implantology and lectures in oral implantology in the Master’s program. He obtained his DDS and MDS degrees at Sapienza University, where he is currently completing his PhD with a focus on bone and tissue regeneration, under the supervision of Prof. G. Pompa. In 2016, Dr Papi was a Visiting Scholar at the University Complutense of Madrid, under the supervision of Prof. G. Pradies. He has authored a number of publications and is a member of the ITI and the EAO.


The runners-up

The second prize was presented to Amruta Joshi BDS, MDS, a private practitioner in Mumbai, India, for her work entitled “In-vivo comparative evaluation of collagen membrane containing recombinant human platelet derived growth factor-BB and autologous platelet rich fibrin membrane when used for periodontal regeneration – a clinical and biochemical study.”


The third prize was awarded to Lennart Kühnel , a medical student and doctoral candidate at the Department of Oral maxillofacial Surgery, University Medical Center Hamburg-Eppendorf in Germany for his work on the “Development of a volume stable barrier membrane for guided bone regeneration based on an HF-coated magnesium mesh combined with a collagen membrane: in vivo biocompatibility, tissue response and bone regeneration.”



About botiss

Based in Berlin, botiss biomaterials is a leading international supplier of oral tissue regeneration products. Its full range of clinically-proven, high quality solutions includes membranes for guided tissue and bone regeneration, a full range of bovine, allogenic and synthetic bone-graft materials, as well as soft-tissue-graft products. botiss is a fast-growing entrepreneurial company, whose products are used in leading clinics across Europe and are backed by many years of clinical experience. The Straumann Group holds a 30% stake in botiss, which is privately owned and was founded in 2008 by Managing Partners Oliver Bielenstein and Dr. Dražen Tadić. Homepage: www.botiss.com.


About Straumann

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Straumann, Neodent, Medentika, ClearCorrect, Dental Wings, and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.


Headquartered in Basel, Switzerland, the Group currently employs approx. 5700 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.